Live Breaking News & Updates on Director Nevan

Stay updated with breaking news from Director nevan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Savara (NASDAQ:SVRA) Shares Down 5.5%

Savara (NASDAQ:SVRA) Shares Down 5.5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Matthew Pauls , Nevanc Elam , Kayne Anderson Rudnick Investment Management , Securities Exchange Commission , Millennium Management , Savara Inc , Renaissance Technologies , Mast Therapeutics Inc , Get Free Report , Exchange Commission , Director Nevan , Street Corp , Street Group , Mast Therapeutics , Savara Daily ,

JMP Securities Initiates Coverage on Savara (NASDAQ:SVRA)

Research analysts at JMP Securities assumed coverage on shares of Savara (NASDAQ:SVRA – Get Free Report) in a note issued to investors on Thursday, Briefing.com reports. The brokerage set an “outperform” rating and a $8.00 price target on the stock. JMP Securities’ price objective indicates a potential upside of 60.00% from the company’s previous close. […] ....

United States , Nevanc Elam , Davidl Lowrance , Schonfeld Strategic Advisors , Savara Company Profile , Board Of Administration Florida Retirement System , Savara Inc , Securities Exchange Commission , Mast Therapeutics Inc , Royal Bank , Get Free Report , Exchange Commission , Director Nevan , Street Group , Florida Retirement System , Strategic Advisors , Mast Therapeutics , Savara Daily , Nasdaq Svra , Initiated Coverage , Jmp Securities ,

Savara (NASDAQ:SVRA) Sets New 1-Year High at $5.29

Savara Inc (NASDAQ:SVRA – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $5.29 and last traded at $5.24, with a volume of 145113 shares traded. The stock had previously closed at $4.99. Analyst Upgrades and Downgrades A number of research firms have […] ....

Matthew Pauls , Nevanc Elam , Royal Bank , Mast Therapeutics Inc , Citigroup Inc , Savara Inc , Squarepoint Ops , Savara Company Profile , Get Free Report , Director Nevan , Street Group , Mast Therapeutics , Savara Daily , Nasdaq Svra ,

Short Interest in Savara Inc (NASDAQ:SVRA) Increases By 22.4%

Savara Inc (NASDAQ:SVRA – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,550,000 shares, an increase of 22.4% from the December 15th total of 2,900,000 shares. Based on an average daily volume of 730,400 shares, the […] ....

Nevanc Elam , Davidl Lowrance , Royal Bank , Citigroup Inc , Savara Inc , Squarepoint Ops , Mast Therapeutics Inc , Get Free Report , Director Nevan , Street Group , Mast Therapeutics , Savara Daily , Nasdaq Svra ,

Savara (NASDAQ:SVRA) Stock Price Down 4.2%

Savara Inc (NASDAQ:SVRA – Get Free Report) shares were down 4.2% on Tuesday . The company traded as low as $4.26 and last traded at $4.32. Approximately 32,624 shares changed hands during trading, a decline of 96% from the average daily volume of 859,317 shares. The stock had previously closed at $4.51. Wall Street Analyst […] ....

Davidl Lowrance , Nevanc Elam , Royal Bank , Savara Company Profile , Topco Ltd , Savara Inc , Securities Exchange Commission , Mast Therapeutics Inc , Principal Financial Group Inc , Victory Capital Management Inc , Get Free Report , Director Nevan , Exchange Commission , Capital Management , Principal Financial Group , Mast Therapeutics , Savara Daily , Nasdaq Svra ,